Controlled Study of Atomoxetine in ADHD
Abstract
Researchers at the Department of Psychiatry, University of Nebraska Medical Center, Omaha, and other centers in the US conducted an 8-week, double-blind, placebo-controlled study of atomoxetine for treatment of ADHD in 101 children 5- and 6-years of age and older.
DOI: https://doi.org/10.15844/pedneurbriefs-25-6-9 | Journal eISSN: 2166-6482
Language: English
Page range: 48 - 48
Published on: Jun 1, 2011
Published by: Pediatric Neurology Briefs Publishers
In partnership with: Paradigm Publishing Services
Keywords:
© 2011 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.